Research Article

You have full text access to this OnlineOpen article

Novel polymorphic AluYb8 insertion in the WNK1 gene is associated with blood pressure variation in Europeans†

  1. Margus Putku1,
  2. Katrin Kepp1,
  3. Elin Org1,
  4. Siim Sõber1,
  5. David Comas2,
  6. Margus Viigimaa3,4,
  7. Gudrun Veldre1,5,
  8. Peeter Juhanson1,
  9. Pille Hallast1,
  10. Neeme Tõnisson1,
  11. HYPEST‡,
  12. Sue Shaw-Hawkins6,
  13. Mark J. Caulfield6,
  14. BRIGHT‡,
  15. Elza Khusnutdinova7,
  16. Viktor Kožich8,
  17. Patricia B. Munroe6,
  18. Maris Laan1,*

Article first published online: 10 MAY 2011

DOI: 10.1002/humu.21508

Issue

Human Mutation

Human Mutation

Volume 32, Issue 7, pages 806–814, July 2011

Additional Information

How to Cite

Putku, M., Kepp, K., Org, E., Sõber, S., Comas, D., Viigimaa, M., Veldre, G., Juhanson, P., Hallast, P., Tõnisson, N., HYPEST, Shaw-Hawkins, S., Caulfield, M. J., BRIGHT, Khusnutdinova, E., Kožich, V., Munroe, P. B. and Laan, M. (2011), Novel polymorphic AluYb8 insertion in the WNK1 gene is associated with blood pressure variation in Europeans. Hum. Mutat., 32: 806–814. doi: 10.1002/humu.21508

Author Information

  1. 1

    Human Molecular Genetics Research Group, Institute of Molecular and Cell Biology, University of Tartu, Tartu, Estonia

  2. 2

    Institute of Evolutionary Biology (UPF-CSIC), CEXS-UPF-PRBB, Universitat Pompeu Fabra, Barcelona, Spain

  3. 3

    Centre of Cardiology, North Estonia Medical Centre, Tallinn, Estonia

  4. 4

    Tallinn University of Technology, Department of Biomedical Engineering, Chair of Medical Physics, Tallinn, Estonia

  5. 5

    Department of Cardiology, University of Tartu, Tartu, Estonia

  6. 6

    Clinical Pharmacology and The Genome Centre, William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London EC1M 6BQ, United Kingdom

  7. 7

    Institute of Biochemistry and Genetics, Ufa Science Center, Russian Academy of Sciences, Ufa, Bashkortostan, Russia

  8. 8

    Institute of Inherited Metabolic Diseases, Charles University—First Faculty of Medicine, Prague, Czech Republic

  1. ‡

    HYPertension in ESTonia (HYPEST), the British Genetics of Hypertension (BRIGHT); additional BRIGHT consortium members are given in Supp. Text S1.

*Institute of Molecular and Cell Biology, University of Tartu, Riia 23, 51010 Tartu, Estonia

  1. †

    Communicated by Pui-Yan Kwok

Publication History

  1. Issue published online: 27 JUN 2011
  2. Article first published online: 10 MAY 2011
  3. Accepted manuscript online: 21 APR 2011 01:28PM EST
  4. Manuscript Accepted: 28 MAR 2011
  5. Manuscript Received: 6 DEC 2010

Funded by

  • Wellcome Trust International Senior Research Fellowships. Grant Numbers: 070191/Z/03/Z (to M.L.), 070255/Z/03/Z (to V.K.) in Biomedical Science in Central Europe
  • The BRIGHT study was supported by the Medical Research Council of Great Britain. Grant Number: G9521010D
  • British Heart Foundation. Grant Number: PG02/128
  • The Barts and The London Charity
  • The HYPEST study was supported by the Estonian Ministry of Education and Science. Grant Number: 0182721s06
  • HHMI International Scholarship. Grant Number: 55005617 (to M.L.)
  • Estonian Science Foundation. Grant Number: ETF7471 (to M.L.; stipend for M.P.)
  • The CADCZ study was supported by the Ministry of Health of the Czech Republic. Grant Number: NS10036-4/2008 (to V.K.)

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article with Supporting Information (HTML) Get PDF (221K)

References

  • Batzer MA, Deininger PL. 2002. Alu repeats and human genomic diversity. Nat Rev Genet 3:370–379.
  • Becquet C, Patterson N, Stone AC, Przeworski M, Reich D. 2007. Genetic structure of chimpanzee populations. PLoS Genet 3:e66.
  • Belancio VP, Hedges DJ, Deininger P. 2008. Mammalian non-LTR retrotransposons: for better or worse, in sickness and in health. Genome Res 18:343–358.
  • Bennett EA, Keller H, Mills RE, Schmidt S, Moran JV, Weichenrieder O, Devine SE. 2008. Active Alu retrotransposons in the human genome. Genome Res 18:1875–1883.
  • Black DL. 2003. Mechanisms of alternative pre-messenger RNA splicing. Annu Rev Biochem 72:291–336.
  • Callinan PA, Batzer MA. 2006. Retrotransposable elements and human disease. Genome Dis 1:104–115.
  • Caulfield M, Munroe P, Pembroke J, Samani N, Dominiczak A, Brown M, Benjamin N, Webster J, Ratcliffe P, O'Shea S, Papp J, Taylor E, Dobson R, Knight J, Newhouse S, Hooper J, Lee W, Brain N, Clayton D, Lathrop GM, Farrall M, Connell J. 2003. Genome-wide mapping of human loci for essential hypertension. Lancet 361:2118–2123.
  • Comas D, Calafell F, Benchemsi N, Helal A, Lefranc G, Stoneking M, Batzer MA, Bertranpetit J, Sajantila A. 2000. Alu insertion polymorphisms in NW Africa and the Iberian Peninsula: evidence for a strong genetic boundary through the Gibraltar Straits. Hum Genet 107:312–319.
  • Cordaux R, Batzer MA. 2009. The impact of retrotransposons on human genome evolution. Nat Rev Genet 10:691–703.
  • Delaloy C, Lu J, Houot AM, Disse-Nicodeme S, Gasc JM, Corvol P, Jeunemaitre X. 2003. Multiple promoters in the WNK1 gene: one controls expression of a kidney-specific kinase-defective isoform. Mol Cell Biol 23:9208–9221.
  • Elgar G, Vavouri T. 2008. Tuning in to the signals: noncoding sequence conservation in vertebrate genomes. Trends Genet 24:344–352.
  • Gibbons R, Dugaiczyk LJ, Girke T, Duistermars B, Zielinski R, Dugaiczyk A. 2004. Distinguishing humans from great apes with AluYb8 repeats. J Mol Biol 339:721–729.
  • Hallast P, Nagirnaja L, Margus T, Laan M. 2005. Segmental duplications and gene conversion: human luteinizing hormone/chorionic gonadotropin beta gene cluster. Genome Res 15:1535–1546.
  • Hardison RC. 2000. Conserved noncoding sequences are reliable guides to regulatory elements. Trends Genet 16:369–372.
  • Hasler J, Strub K. 2006. Alu elements as regulators of gene expression. Nucleic Acids Res 34:5491–5497.
  • Higaki J, Baba S, Katsuya T, Sato N, Ishikawa K, Mannami T, Ogata J, Ogihara T. 2000. Deletion allele of angiotensin-converting enzyme gene increases risk of essential hypertension in Japanese men: the Suita Study. Circulation 101:2060–2065.
  • Janosikova B, Pavlikova M, Kocmanova D, Vitova A, Vesela K, Krupkova L, Kahleova R, Krijt J, Kraml P, Hyanek J, Zvarova J, Andel M, Kozich V. 2003. Genetic variants of homocysteine metabolizing enzymes and the risk of coronary artery disease. Mol Genet Metab 79:167–175.
  • Ji W, Foo JN, O'Roak BJ, Zhao H, Larson MG, Simon DB, Newton-Cheh C, State MW, Levy D, Lifton RP. 2008. Rare independent mutations in renal salt handling genes contribute to blood pressure variation. Nat Genet 40:592–599.
  • Kokubo Y, Kamide K, Inamoto N, Tanaka C, Banno M, Takiuchi S, Kawano Y, Tomoike H, Miyata T. 2004. Identification of 108 SNPs in TSC, WNK1, and WNK4 and their association with hypertension in a Japanese general population. J Hum Genet 49:507–515.
  • Lifton RP, Gharavi AG, Geller DS. 2001. Molecular mechanisms of human hypertension. Cell 104:545–556.
  • Muller PY, Janovjak H, Miserez AR, Dobbie Z. 2002. Processing of gene expression data generated by quantitative real-time RT-PCR. Biotechniques 32:1372–1374, 1376, 1378–1379.
  • Newhouse S, Farrall M, Wallace C, Hoti M, Burke B, Howard P, Onipinla A, Lee K, Shaw-Hawkins S, Dobson R, Brown M, Samani NJ, Dominiczak AF, Connell JM, Lathrop GM, Kooner J, Chambers J, Elliott P, Clarke R, Collins R, Laan M, Org E, Juhanson P, Veldre G, Viigimaa M, Eyheramendy S, Cappuccio FP, Ji C, Iacone R, Strazzullo P, Kumari M, Marmot M, Brunner E, Caulfield M, Munroe PB. 2009. Polymorphisms in the WNK1 gene are associated with blood pressure variation and urinary potassium excretion. PLoS One 4:e5003.
  • Newhouse SJ, Wallace C, Dobson R, Mein C, Pembroke J, Farrall M, Clayton D, Brown M, Samani N, Dominiczak A, Connell JM, Webster J, Lathrop GM, Caulfield M, Munroe PB. 2005. Haplotypes of the WNK1 gene associate with blood pressure variation in a severely hypertensive population from the British Genetics of Hypertension study. Hum Mol Genet 14:1805–1814.
  • O'Donnell CJ, Lindpaintner K, Larson MG, Rao VS, Ordovas JM, Schaefer EJ, Myers RH, Levy D. 1998. Evidence for association and genetic linkage of the angiotensin-converting enzyme locus with hypertension and blood pressure in men but not women in the Framingham Heart Study. Circulation 97:1766–1772.
  • Osada Y, Miyauchi R, Goda T, Kasezawa N, Horiike H, Iida M, Sasaki S, Yamakawa-Kobayashi K. 2009. Variations in the WNK1 gene modulates the effect of dietary intake of sodium and potassium on blood pressure determination. J Hum Genet 54:474–478.
  • Padmanabhan S, Menni C, Lee WK, Laing S, Brambilla P, Sega R, Perego R, Grassi G, Cesana G, Delles C, Mancia G, Dominiczak AF. 2010. The effects of sex and method of blood pressure measurement on genetic associations with blood pressure in the PAMELA study. J Hypertens 28:465–477.
  • Pastinen T, Hudson TJ. 2004. Cis-acting regulatory variation in the human genome. Science 306:647–650.
  • Ptak SE, Roeder AD, Stephens M, Gilad Y, Paabo S, Przeworski M. 2004. Absence of the TAP2 human recombination hotspot in chimpanzees. PLoS Biol 2:e155.
  • Rice P, Longden I, Bleasby A. 2000. EMBOSS: the European Molecular Biology Open Software Suite. Trends Genet 16:276–277.
  • Rigat B, Hubert C, Alhenc-Gelas F, Cambien F, Corvol P, Soubrier F. 1990. An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest 86:1343–1346.
  • Rozen S, Skaletsky H. 2000. Primer3 on the WWW for general users and for biologist programmers. Methods Mol Biol 132:365–386.
  • Sabolic I, Asif AR, Budach WE, Wanke C, Bahn A, Burckhardt G. 2007. Gender differences in kidney function. Pflugers Arch 455:397–429.
  • Stankovic A, Zivkovic M, Alavantic D. 2002. Angiotensin I-converting enzyme gene polymorphism in a Serbian population: a gender-specific association with hypertension. Scand J Clin Lab Invest 62:469–475.
  • Tobin MD, Raleigh SM, Newhouse S, Braund P, Bodycote C, Ogleby J, Cross D, Gracey J, Hayes S, Smith T, Ridge C, Caulfield M, Sheehan NA, Munroe PB, Burton PR, Samani NJ. 2005. Association of WNK1 gene polymorphisms and haplotypes with ambulatory blood pressure in the general population. Circulation 112:3423–3429.
  • Tobin MD, Timpson NJ, Wain LV, Ring S, Jones LR, Emmett PM, Palmer TM, Ness AR, Samani NJ, Smith GD, Burton PR. 2008. Common variation in the WNK1 gene and blood pressure in childhood: the Avon Longitudinal Study of Parents and Children. Hypertension 52:974–979.
  • Turner ST, Schwartz GL, Chapman AB, Boerwinkle E. 2005. WNK1 kinase polymorphism and blood pressure response to a thiazide diuretic. Hypertension 46:758–765.
  • Vehaskari VM. 2007. Heritable forms of hypertension. Pediatr Nephrol 24:1929–1937.
  • Verissimo F, Jordan P. 2001. WNK kinases, a novel protein kinase subfamily in multi-cellular organisms. Oncogene 20:5562–5569.
  • Visel A, Rubin EM, Pennacchio LA. 2009. Genomic views of distant-acting enhancers. Nature 461:199–205.
  • Watkins WS, Ricker CE, Bamshad MJ, Carroll ML, Nguyen SV, Batzer MA, Harpending HC, Rogers AR, Jorde LB. 2001. Patterns of ancestral human diversity: an analysis of Alu-insertion and restriction-site polymorphisms. Am J Hum Genet 68:738–752.
  • Watkins WS, Rogers AR, Ostler CT, Wooding S, Bamshad MJ, Brassington AM, Carroll ML, Nguyen SV, Walker JA, Prasad BV, Reddy PG, Das PK, Batzer MA, Jorde LB. 2003. Genetic variation among world populations: inferences from 100 Alu insertion polymorphisms. Genome Res 13:1607–1618.
  • Wilson FH, Disse-Nicodeme S, Choate KA, Ishikawa K, Nelson-Williams C, Desitter I, Gunel M, Milford DV, Lipkin GW, Achard JM, Feely MP, Dussol B, Berland Y, Unwin RJ, Mayan H, Simon DB, Farfel Z, Jeunemaitre X, Lifton RP. 2001. Human hypertension caused by mutations in WNK kinases. Science 293:1107–1112.
  • Wilson FH, Kahle KT, Sabath E, Lalioti MD, Rapson AK, Hoover RS, Hebert SC, Gamba G, Lifton RP. 2003. Molecular pathogenesis of inherited hypertension with hyperkalemia: the Na-Cl cotransporter is inhibited by wild-type but not mutant WNK4. Proc Natl Acad Sci USA 100:680–684.
  • Xu B, English JM, Wilsbacher JL, Stippec S, Goldsmith EJ, Cobb MH. 2000. WNK1, a novel mammalian serine/threonine protein kinase lacking the catalytic lysine in subdomain II. J Biol Chem 275:16795–16801.
  • Xu Q, Modrek B, Lee C. 2002. Genome-wide detection of tissue-specific alternative splicing in the human transcriptome. Nucleic Acids Res 30:3366–3754.
View Full Article with Supporting Information (HTML) Get PDF (221K)